InBody Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
6,194
8,879
17,315
16,989
19,331
Depreciation, Depletion & Amortization
922
1,109
1,369
1,748
1,751
Other Funds
-
26
-
-
-
Funds from Operations
8,063
10,645
20,559
19,565
23,154
Changes in Working Capital
1,069
386
9,381
1,326
4,578
Net Operating Cash Flow
6,995
10,259
11,179
18,238
18,576
Capital Expenditures
9,367
1,622
7,550
8,405
5,581
Sale of Fixed Assets & Businesses
3
95
24
100
29
Purchase/Sale of Investments
2,971
7,634
2,542
5,232
7,150
Net Investing Cash Flow
6,390
9,107
9,683
12,614
13,067
Cash Dividends Paid - Total
545
545
817
1,089
1,361
Net Financing Cash Flow
545
518
817
1,089
4,215
Net Change in Cash
166
322
925
4,645
951
Free Cash Flow
2,263
8,792
3,863
10,607
13,264
Other Sources
86
54
704
1,967
86
Change in Capital Stock
-
-
-
-
2,853
Exchange Rate Effect
226
312
246
110
343
Other Uses
83
-
320
1,044
451

About InBody Co.

View Profile
Address
InBody Building
Seoul SL 06313
Korea, Republic Of
Employees -
Website http://www.inbody.com
Updated 09/14/2018
InBody Co., Ltd. engages in the manufacture and sale of medical equipment. Its products include body composition analyzers, automatic shpygmomanometers, and extensometers. The company was founded by Cha Ki-Chul on May 15, 1996 and is headquartered in Seoul, South Korea.